Skip to main content

Table 1 General characteristics

From: Prognostic implications of tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure ratio in septic shock patients

CategoriesSurvivors (n = 75)Non-survivors (n = 43)p value
Age (yr)59.3 ± 15.367.6 ± 14.10.004
Sex (male, %)47 (62.6%)29 (67.4%)0.590
APACHE II18 (14, 22)26 (19, 30)< 0.001
SOFA12 (10, 13)14 (12, 16)< 0.001
Diagnosis (n, %)
 Pneumonia15 (20.0%)13 (30.2%)0.208
 Abdominal infection38 (50.7%)17 (39.5%)0.250
 Biliary tract infection4 (5.3%)2 (4.7%)0.863
 CRBSI4 (5.3%)2 (4.7%)0.863
 Cellulitis10 (13.3%)5 (11.6%)0.802
 Others*4 (5.3%)4 (9.3%)0.405
Comorbidities
 HTN36 (48.0%)25 (58.1%)0.284
 DM28 (37.3%)22 (51.2%)0.143
 CAD14 (18.7%)13 (30.2%)0.147
 CKD5 (6.7%)6 (14.0%)0.194
 COPD7 (9.3%)8 (18.6%)0.151
 Timing of echo (hr from admission)12 (8,18)13 (9, 16)0.905
 Maximum NE dose (μg/kg/min)0.36 (0.18, 0.75)0.81 (0.40, 1.61)0.001
 Fluid administered (ml)2560 (1366, 3140)2880 (1629, 3530)0.766
 Lactate (mmol/L)3.5 (2.7, 4.2)4.0 (3.3, 4.9)0.185
 MV duration (hr)108 (67, 240)203 (105, 340)0.051
 ICU length of stay (day)7 (4, 12)10 (6, 15)0.233
  1. TAPSE tricuspid annular plane systolic excursion, APACHE acute physiology and chronic health evaluation, SOFA sequential organ failure assessment, UTI urinary tract infection, CRBSI catheter related bloodstream infection, HTN hypertension, DM diabetes mellitus, CAD coronary arterial disease, CKD chronic kidney dysfunction, COPD chronic obstructive pulmonary disease, NE norepinephrine, ICU intensive care unit
  2. *Others including urinary tract infection, intracranial, mediastinum infections